Xavier Jacq
Chief Scientific Officer MitoRx Therapeutics Limited
Seminars
Wednesday 28th October 2026
Targeting Mitochondrially Unhealthy Obesity to Provide an Alternative Mode of Action for Obesity Therapeutics
3:00 pm
- Developing a differentiated mode of action from appetite suppression to generate as good efficacy of dual incretins
- Restoring mitochondrial function with a new mode of action to target obesity
- Targeting energy expenditure form switching to carbohydrate
- Exploring metabolic and obesity drivers
Thursday 29th October 2026
Panel Discussion: Evaluating Opportunities to Improve Long-Term Weight Loss Management
3:00 pm
- Decreasing BMI and pricing barriers to patient access of obesity and weight loss medication
- Exploring therapeutic and non-therapeutic methods to ensure weight maintenance beyond initial therapeutic application
